KINASE INHIBITORS
US Application 63/527,274
Filed on 2023-07-17
Filed on 2023-07-17
POLYFLUORINATED THALIDOMIDE ANALOGS AND USES THEREOF
US Application 63/518,823
Filed on 2023-08-10
Filed on 2023-08-10
VACCINE FOR HUMAN T-LYMPHOTROPIC VIRUS-1
Patent Cooperation Treaty
PCT/US2023/066839
Filed on 2023-05-10
PCT/US2023/066839
Filed on 2023-05-10
LASSA VIRUS-SPECIFIC NANOBODIES AND METHODS OF THEIR USE
Patent Cooperation Treaty
PCT/US2022/027082
Filed on 2022-04-29
PCT/US2022/027082
Filed on 2022-04-29
AUTOMATIC SYSTEM AND METHOD FOR TISSUE SECTIONING, STAINING, AND SCANNING
Japan
2021-555576
Filed on 2021-09-14
2021-555576
Filed on 2021-09-14
Zinbryta® for Treatment of Relapsing Multiple Sclerosis
The 2017 Deals of Distinction™ Award was presented to National Institutes of Health, (NIH) along with its corporate partners, AbbVie and Biogen, for a license agreement related to the development and launch of Zinbryta® for treatment of relapsing multiple sclerosis (MS) The award, one of the most prestigious for technology transfer, was given to NIH and its partners at the Licensing Executives Society Annual Meeting in Chicago, Illinois.